Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Q32 Bio ( (QTTB) ) has issued an announcement.
On March 27, 2026, Q32 Bio Inc. entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co., enabling at-the-market sales of its common stock under a prospectus supplement for up to $14.2 million. Having now sold the full $14.2 million by the date of the latest filing, the company has terminated that initial prospectus supplement and ceased further sales under it.
On April 24, 2026, Q32 Bio filed a new prospectus supplement to sell up to an additional $75 million of common stock under the same sales agreement, leveraging its effective shelf registration statement on Form S-3. This expanded at-the-market capacity significantly increases the company’s potential access to equity capital, which may have implications for its financing flexibility and future dilution for existing shareholders.
The most recent analyst rating on (QTTB) stock is a Buy with a $13.00 price target. To see the full list of analyst forecasts on Q32 Bio stock, see the QTTB Stock Forecast page.
Spark’s Take on QTTB Stock
According to Spark, TipRanks’ AI Analyst, QTTB is a Neutral.
The score is held back mainly by weak operating fundamentals—near-zero recurring revenue and persistent cash burn—despite some balance sheet repair. Technicals are a clear positive with an upward trend and moderate momentum, while the very low P/E is less persuasive given earnings quality concerns; recent capital-raise activity supports liquidity but introduces dilution risk.
To see Spark’s full report on QTTB stock, click here.
More about Q32 Bio
Q32 Bio Inc. is a biopharmaceutical company focused on developing immune-driven disease therapies and operates in the life sciences sector. The company accesses capital markets through at-the-market equity programs, issuing common stock to support its development pipeline and corporate operations as needed.
Average Trading Volume: 279,076
Technical Sentiment Signal: Buy
Current Market Cap: $94.8M
Find detailed analytics on QTTB stock on TipRanks’ Stock Analysis page.